AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35162891 — intervention group
Group type: COMPARATOR
Intervention: Regular routine care
Number of subjects: 100
Study 32943236 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck dissection (ND)
Number of subjects: 105
Study 35848358 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard (ST) preoperative chemotherapy
Number of subjects: 86
Study 35848358 — intervention group
Group type: EXPERIMENTAL
Intervention: Histotype-tailored (HT) preoperative chemotherapy
Number of subjects: 86
Study 35848358 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard (S) chemotherapy
Number of subjects: 86
Study 35848358 — intervention group
Group type: EXPERIMENTAL
Intervention: Histotype-tailored (HT) chemotherapy
Number of subjects: 86
Study 35848358 — intervention group
Group type: EXPERIMENTAL
Intervention: CINSARC scoring
Number of subjects: 86
Study 34449183 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 1426
Study 34449183 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K Antagonists
Number of subjects: 1426
Study 33719265 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mmHg (group L)
Number of subjects: 27
Study 33719265 — intervention group
Group type: EXPERIMENTAL
Intervention: 180 mmHg (group H)
Number of subjects: 27
Study 33719265 — intervention group
Group type: COMPARATOR
Intervention: 0 mmHg (group C)
Number of subjects: 27
Study 35524184 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 540
Study 35524184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study 33252985 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF 320 (320/18/9.6 μg)
Number of subjects: 8509
Study 33252985 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF 160 (160/18/9.6 μg)
Number of subjects: 8509
Study 33252985 — intervention group
Group type: COMPARATOR
Intervention: GFF (18/9.6 μg)
Number of subjects: 8509
Study 33252985 — intervention group
Group type: COMPARATOR
Intervention: BFF (320/9.6 μg)
Number of subjects: 8509
Study 35050796 — intervention group
Group type: EXPERIMENTAL
Intervention: Apnea training (5 maximal static apneas daily for 6 weeks)
Number of subjects: 22
Study 35050796 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 22
Study 35050796 — intervention group
Group type: EXPERIMENTAL
Intervention: Apnea training
Number of subjects: 22
Study 33745107 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvenous phrenic nerve stimulation (TPNS)
Number of subjects: 151
Study 33745107 — intervention group
Group type: COMPARATOR
Intervention: Deferred therapy (control)
Number of subjects: 151
Study 32212314 — intervention group
Group type: EXPERIMENTAL
Intervention: Myriocin exposure
Number of subjects: 0
Study 32212314 — intervention group
Group type: EXPERIMENTAL
Intervention: Clone LH03
Number of subjects: 0
Study 32212314 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-driven adaptive laboratory evolution (ALE)
Number of subjects: 0
Study 35760762 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Load Eccentric Exercise (LL)
Number of subjects: 60
Study 35760762 — intervention group
Group type: EXPERIMENTAL
Intervention: High Load Eccentric Exercise with Blood Flow Restriction (HL-BFR)
Number of subjects: 60
Study 35760762 — intervention group
Group type: EXPERIMENTAL
Intervention: High Load Eccentric Exercise (HL)
Number of subjects: 60
Study 35760762 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Load Eccentric Exercise with Blood Flow Restriction (LL-BFR)
Number of subjects: 60
Study 34213860 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI) for 2 weeks
Number of subjects: 38
Study 34213860 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation and resting (PER)
Number of subjects: 38
Study 36426763 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio-Taiso exercise program (3-5 min sessions, 1-4 times per day for 12 weeks)
Number of subjects: 58
Study 36426763 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio-Taiso exercise program
Number of subjects: 58
Study 36426763 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 58
Study 33651027 — intervention group
Group type: COMPARATOR
Intervention: Effervescent tablet (ET)
Number of subjects: 344
Study 33651027 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan solution (CH)
Number of subjects: 344
Study 33651027 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan nanoparticle solution (CN)
Number of subjects: 344
Study 33651027 — intervention group
Group type: COMPARATOR
Intervention: Control solution (WC)
Number of subjects: 344
Study 32060217 — intervention group
Group type: EXPERIMENTAL
Intervention: dPET
Number of subjects: 66
Study 32060217 — intervention group
Group type: COMPARATOR
Intervention: cPET
Number of subjects: 66
Study 35667775 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L crosswalk
Number of subjects: 361
Study 35667775 — intervention group
Group type: EXPERIMENTAL
Intervention: ReQoL-UI
Number of subjects: 361
Study 35667775 — intervention group
Group type: COMPARATOR
Intervention: Complete case ReQoL-UI baseline-adjusted QALYs
Number of subjects: 361
Study 35667775 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-imputation EQ-5D-5L crosswalk unadjusted QALYs
Number of subjects: 361
Study 35667775 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 361
Study 35667775 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm
Number of subjects: 361
Study 33641272 — intervention group
Group type: EXPERIMENTAL
Intervention: DSE + MET (n=41)
Number of subjects: 125
Study 33641272 — intervention group
Group type: COMPARATOR
Intervention: DSE alone (n=39)
Number of subjects: 125
Study 33641272 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (n=45)
Number of subjects: 125
Study 33641272 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional disability
Number of subjects: 125
Study 35777128 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 136
Study 35777128 — intervention group
Group type: COMPARATOR
Intervention: Relapse Prevention-Cognitive Behavioral Therapy (CBT-RP)
Number of subjects: 136
Study 32634046 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloons (DCB)
Number of subjects: 0
Study 32634046 — intervention group
Group type: COMPARATOR
Intervention: Best-in-class drug-eluting stents (DES)
Number of subjects: 0
Study 35835136 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT)
Number of subjects: 598
Study 35835136 — intervention group
Group type: COMPARATOR
Intervention: Punch biopsy (regular care)
Number of subjects: 598
Study 33809346 — intervention group
Group type: EXPERIMENTAL
Intervention: GA with SPI-guided FNT administration
Number of subjects: 176
Study 33809346 — intervention group
Group type: COMPARATOR
Intervention: Preventive topical 2% proparacaine (TA)
Number of subjects: 176
Study 33809346 — intervention group
Group type: COMPARATOR
Intervention: Preprocedural peribulbar block (PBB) using 0.5% bupivacaine with 2% lidocaine
Number of subjects: 176
Study 33809346 — intervention group
Group type: COMPARATOR
Intervention: Preprocedural intravenous infusion of 1.0 g of metamizole (M)
Number of subjects: 176
Study 33809346 — intervention group
Group type: COMPARATOR
Intervention: Preprocedural intravenous infusion of 1.0 g of paracetamol (P)
Number of subjects: 176
Study 32615575 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD
Number of subjects: 500
Study 35707478 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure on points Ren3, Ren4, Liv3, Sp6, and Sp10
Number of subjects: 96
Study 35707478 — intervention group
Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 96
Study 33573600 — intervention group
Group type: EXPERIMENTAL
Intervention: Global procedure
Number of subjects: 9
Study 33573600 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential procedure
Number of subjects: 9
Study 33573600 — intervention group
Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 9
Study 32513312 — intervention group
Group type: EXPERIMENTAL
Intervention: Transgenic Camelina sativa seed oil (CSO) 450 mg/d EPA + DHA for 8 weeks
Number of subjects: 31
Study 32513312 — intervention group
Group type: COMPARATOR
Intervention: Fish oil (FO) 450 mg/d EPA + DHA for 8 weeks
Number of subjects: 31
Study 35476192 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) and communication intervention during the procedure
Number of subjects: 100
Study 35476192 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine surgical treatment)
Number of subjects: 100
Study 32223344 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 20
Study 32223344 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 20
Study 34476452 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing emulsifier 30
Number of subjects: 60
Study 34476452 — intervention group
Group type: COMPARATOR
Intervention: Fluoride toothpaste containing sodium lauryl sulfate (SLS) surfactant
Number of subjects: 60
Study 34476452 — intervention group
Group type: EXPERIMENTAL
Intervention: Both toothpaste types
Number of subjects: 60
Study 32845864 — intervention group
Group type: EXPERIMENTAL
Intervention: Myrtus communis fruits (powdered)
Number of subjects: 40
Study 32845864 — intervention group
Group type: COMPARATOR
Intervention: Tranexamic acid
Number of subjects: 40
Study 35354339 — intervention group
Group type: EXPERIMENTAL
Intervention: Emulsion cream containing 0.05% APP in triglycerides (APP preparation)
Number of subjects: 54
Study 35354339 — intervention group
Group type: COMPARATOR
Intervention: Mineral oil hydrocarbon (petrolatum)-based skin cream (MHB preparation)
Number of subjects: 54
Study 35354339 — intervention group
Group type: EXPERIMENTAL
Intervention: Both APP and MHB preparations
Number of subjects: 54
Study 34125080 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized PEEP guided by minimum driving pressure
Number of subjects: 148
Study 34125080 — intervention group
Group type: COMPARATOR
Intervention: Fixed PEEP of 6 cm H2O
Number of subjects: 148
Study 32633762 — intervention group
Group type: EXPERIMENTAL
Intervention: Health care exposures before hospital admission for sepsis
Number of subjects: 1078
Study 32633762 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient encounters in the 7 days before admission
Number of subjects: 1078
Study 32633762 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment in the 30 days before admission
Number of subjects: 1078
Study 32633762 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification of sepsis-associated pathogens
Number of subjects: 1078
Study 32633762 — intervention group
Group type: EXPERIMENTAL
Intervention: Underlying comorbidities and 30-day mortality
Number of subjects: 1078
Study 35807851 — intervention group
Group type: EXPERIMENTAL
Intervention: Isocaloric dietary protein restriction (PR; n = 10, diet of 8409 2360 KJ per day)
Number of subjects: 21
Study 35807851 — intervention group
Group type: COMPARATOR
Intervention: Caloric restriction (CR; n = 11, diet of 5941 686 KJ per day)
Number of subjects: 21
Study 35807851 — intervention group
Group type: EXPERIMENTAL
Intervention: Isocaloric dietary protein restriction (PR)
Number of subjects: 21
Study 35807851 — intervention group
Group type: COMPARATOR
Intervention: Caloric restriction (CR)
Number of subjects: 21
Study 34238100 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-led follow-up (education and self-referral to project nurse)
Number of subjects: 512
Study 34238100 — intervention group
Group type: COMPARATOR
Intervention: Standard follow-up (routine clinical doctor visits)
Number of subjects: 512
Study 32653726 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal isolates
Number of subjects: 537
Study 34274366 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation (MV) on, tidal volume (TV) at 3-4 mL.kg-1 (Group 2)
Number of subjects: 60
Study 34274366 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation (MV) on, tidal volume (TV) at 3-4 mL.kg-1, PEEP at 5 cmH2O (Group 3)
Number of subjects: 60
Study 34274366 — intervention group
Group type: COMPARATOR
Intervention: Mechanical ventilation off (Group 1)
Number of subjects: 60
Study 33449169 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week physical activity (PA) intervention
Number of subjects: 16
Study 33449169 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 16
Study 32575919 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified experimental group
Number of subjects: 127
Study 32575919 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 127
Study 35512392 — intervention group
Group type: EXPERIMENTAL
Intervention: Deceptive Placebo
Number of subjects: 201
Study 35512392 — intervention group
Group type: COMPARATOR
Intervention: Open Placebo
Number of subjects: 201
Study 35512392 — intervention group
Group type: COMPARATOR
Intervention: No Placebo
Number of subjects: 201
Study 35512392 — intervention group
Group type: EXPERIMENTAL
Intervention: Beliefs about pharmaceuticals
Number of subjects: 201
Study 35512392 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived sensitivity to medicines
Number of subjects: 201
Study 35512392 — intervention group
Group type: EXPERIMENTAL
Intervention: Concerns about Modafinil
Number of subjects: 201
Study 35512392 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative affectivity
Number of subjects: 201
Study 32297822 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactive cement (ACTIVA)
Number of subjects: 30
Study 32297822 — intervention group
Group type: COMPARATOR
Intervention: Glass ionomer cement (GIC; Ketac Cem)
Number of subjects: 30
Study 32297822 — intervention group
Group type: COMPARATOR
Intervention: Resin luting agent (Nexus 3)
Number of subjects: 30
Study 34516459 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 200 mg daily for 3 weeks
Number of subjects: 61
Study 34516459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 34171518 — intervention group
Group type: EXPERIMENTAL
Intervention: TENSE training program (three-day training course and two follow-up sessions)
Number of subjects: 297
Study 34171518 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 297
Study 32479206 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultivars with varying resistance levels to RLNs
Number of subjects: 0
Study 32479206 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultivars with equivalent exposures to presowing and postharvest RLN densities
Number of subjects: 0
Study 32479206 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed design and analysis approach
Number of subjects: 0
Study 36153016 — intervention group
Group type: EXPERIMENTAL
Intervention: Motion control shoes
Number of subjects: 40
Study 36153016 — intervention group
Group type: COMPARATOR
Intervention: Neutral shoes
Number of subjects: 40
Study 34344633 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual classroom session on Second Life®
Number of subjects: 0
Study 34344633 — intervention group
Group type: COMPARATOR
Intervention: Traditional face-to-face classroom session
Number of subjects: 0
Study 34657193 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day preparation with Sodium Picosulfate/Magnesium Citrate (SPMC)
Number of subjects: 197
Study 34657193 — intervention group
Group type: COMPARATOR
Intervention: Split-dose preparation with Sodium Picosulfate/Magnesium Citrate (SPMC)
Number of subjects: 197
Study 33277698 — intervention group
Group type: EXPERIMENTAL
Intervention: Mulberry leaf DNJ (MLD) treatment
Number of subjects: 0
Study 33277698 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (CG)
Number of subjects: 0
Study 32740593 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-incision negative-pressure therapy
Number of subjects: 91
Study 32740593 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-incision negative-pressure therapy malfunction
Number of subjects: 91
Study 32740593 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-incision negative-pressure therapy duration longer than 10 days
Number of subjects: 91
Study 32424421 — intervention group
Group type: EXPERIMENTAL
Intervention: New biomarkers for treatment selection
Number of subjects: 0
Study 32424421 — intervention group
Group type: COMPARATOR
Intervention: Standard biomarkers for treatment selection
Number of subjects: 0
Study 33691344 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin-based bismuth-containing quadruple therapy (C-BQT)
Number of subjects: 350
Study 33691344 — intervention group
Group type: EXPERIMENTAL
Intervention: Furazolidone-based bismuth-containing quadruple therapy (F-BQT)
Number of subjects: 350
Study 33691344 — intervention group
Group type: COMPARATOR
Intervention: Cumulative eradication rates of C-F group
Number of subjects: 350
Study 33691344 — intervention group
Group type: COMPARATOR
Intervention: Cumulative eradication rates of F-C group
Number of subjects: 350
Study 32580666 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (3 months, 3 times per week)
Number of subjects: 45
Study 32580666 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle training (3 months, 3 times per week)
Number of subjects: 45
Study 32580666 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 45
Study 32826832 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour recovery trial
Number of subjects: 10
Study 32826832 — intervention group
Group type: EXPERIMENTAL
Intervention: 48-hour recovery trial
Number of subjects: 10
Study 32826832 — intervention group
Group type: EXPERIMENTAL
Intervention: Both recovery periods
Number of subjects: 10
Study 32826832 — intervention group
Group type: COMPARATOR
Intervention: Beach volleyball drills and match performance
Number of subjects: 10
Study 32114925 — intervention group
Group type: EXPERIMENTAL
Intervention: Hadamard-coded modulation (HCM)
Number of subjects: 0
Study 32114925 — intervention group
Group type: EXPERIMENTAL
Intervention: DC-reduced HCM (DCR-HCM)
Number of subjects: 0
Study 32114925 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple lamps transmitting the same data
Number of subjects: 0
Study 32114925 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial distribution of maximum throughput
Number of subjects: 0
Study 35713224 — intervention group
Group type: EXPERIMENTAL
Intervention: AI group (n = 16)
Number of subjects: 53
Study 35713224 — intervention group
Group type: EXPERIMENTAL
Intervention: AIHC group (n = 17)
Number of subjects: 53
Study 35713224 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG; n = 20)
Number of subjects: 53
Study 33358848 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) or medication
Number of subjects: 0
Study 32791313 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) with a conditioning-test paired-pulse paradigm, applying the conditioning stimulus to the right primary motor cortex and the test stimulus to the left primary motor cortex.
Number of subjects: 0
Study 32791313 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) measuring latency distribution of transcallosal fibers.
Number of subjects: 0
Study 34799776 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) with 2 J red laser and 3 J infrared laser on 21 points on the tongue
Number of subjects: 112
Study 34799776 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (simulated PBMT)
Number of subjects: 112
Study 34799776 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 112
Study 34321035 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-based gamified exercise platform
Number of subjects: 24
Study 34321035 — intervention group
Group type: COMPARATOR
Intervention: Computer-based configuration (no robot)
Number of subjects: 24
Study 35509104 — intervention group
Group type: EXPERIMENTAL
Intervention: ICH-LR2S2 risk score
Number of subjects: 70540
Study 35509104 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning methods such as XGboost
Number of subjects: 70540
Study 35509104 — intervention group
Group type: EXPERIMENTAL
Intervention: ICH-LR2S2 risk score on external validation cohort
Number of subjects: 70540
Study 33506357 — intervention group
Group type: EXPERIMENTAL
Intervention: Tart cherry juice (240 ml)
Number of subjects: 48
Study 33506357 — intervention group
Group type: EXPERIMENTAL
Intervention: Tart cherry powdered capsule (480 mg)
Number of subjects: 48
Study 33506357 — intervention group
Group type: EXPERIMENTAL
Intervention: Tart cherry powdered capsule (480 mg, two capsules)
Number of subjects: 48
Study 33506357 — intervention group
Group type: COMPARATOR
Intervention: Placebo (not specified)
Number of subjects: 48
Study 33140515 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel 80 mg/m2 weekly for 12 doses followed by FAC/FEC
Number of subjects: 51
Study 33140515 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin 1.4 mg/m2 on days 1 and 8 of a 21-day cycle for 4 cycles followed by FAC/FEC
Number of subjects: 51
Study 33140515 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 51
Study 33140515 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 51
Study 32134332 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone‐anchored maxillary protraction (BAMP) not preceded by maxillary expansion
Number of subjects: 28
Study 32134332 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone‐anchored maxillary protraction (BAMP) preceded by maxillary expansion
Number of subjects: 28
Study 36384081 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet (4 g/day)
Number of subjects: 29
Study 36384081 — intervention group
Group type: COMPARATOR
Intervention: Moderate FODMAP diet (23 g/day)
Number of subjects: 29
Study 33504175 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation and Therapeutic Exposure for Grief
Number of subjects: 155
Study 33504175 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Therapy for Grief
Number of subjects: 155
Study 32772701 — intervention group
Group type: EXPERIMENTAL
Intervention: Taping
Number of subjects: 31
Study 32772701 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 31
Study 36164681 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided selective nerve root block (SNRB)
Number of subjects: 156